The contribution of phagocytes to the early protection of mice inoculated intravenously with influenza virus was investigated in phagocyte-depleted mice. Following the inoculation of a sublethal dose of influenza virus, virus titres in the liver and lung of both untreated and carrageenan-treated mice were reduced rapidly by day 1 and decreased slowly to reach an undetectable level by day 7. The titres in y-irradiated mice decreased transiently by day 1 and increased progressively thereafter to kill all of the hosts by day 8. The clearance of virus from blood at the early stage of infection was retarded by y-irradiation but not by carrageenan treatment. In addition, increase in virus titres in the liver and lung in the early stage of the infection was prevented by adoptive transfer with syngeneic polymorphonuclear leukocytes into y-irradiated mice. No significant rise of neutralizing antibody was detectable by day 3 after the inoculation, in any of the three groups of mice. These observations imply that ysensitive and carrageenan-resistant polymorphonuclear leukocytes play a protective role at the early stage in the infection, whereas fixed macrophages or natural killer cells, both of which are carrageenan-sensitive and y-resistant, scarcely participate in the early phase.
INTRODUCTION
Phagocytes consisting mainly of polymorphonuclear leukocytes (PMN) and macrophages have differential susceptibilities to X-ray irradiation and carrageenan. PMN are highly sensitive to X-irradiation but resistant to carrageenan, while mononuclear phagocytes, tissue macrophages and blood monocytes are sensitive to carrageenan and, with the exception of the monocytes, are resistant to X-irradiation (Benacerraf et al., 1959; Kornfeld & Greenman, 1966; Volkman & Collins, 1971; Gillette & Lance, 1973) . These two series of phagocytes play indispensable roles in protection at the early stage of infection with a variety of bacteria and afford differing degrees of protection, depending on individual microorganisms. PMN contribute mainly to the early phase of protection against extracellular Gram-negative bacteria such as Pseudomonas aeruginosa (Tatsukawa et at., 1979) and Escherichia coli (Tsuru et al ., 1981) whereas the protection against intracellular bacteria such as Listeria monocytogenes (Tatsukawa et al., 1979) is highly dependent upon mononuclear phagocytes of the macrophage series. The relative contribution of these two series of phagocytes to the early protection against generalized virus infections has not been established. Studies in our laboratory (Tsuru et al., 1983) indicated that protection during the early phase of ectromelia virus infection depended upon macrophages and not upon cell-mediated immunity.
In the case of influenza virus infection, prevention of and recovery from infection of the mouse are attributable to both humoral and cellular immunities. Antibody to haemagglutinin or 0000-7262 neuraminidase protects against the virus and cytotoxic T cells play a significant role in recovery (Askonas et al., 1982; Ada et aL, 1983 ; Mitchell et al., 1985) . Although macrophages and natural killer (NK) cells probably participate in non-specific defence against influenza virus infection Gangemi et al., 1983) , the effector cells responsible for early protection have not been clearly defined. The present study investigates the contribution of phagocytes to early protection following intravenous inoculation of influenza virus.
METHODS
Mice. Female BALB/c mice obtained from Charles River Japan, Inc. (Kanagawa, Japan) were used at 6 to 8 weeks of age.
Viruses.
Influenza virus strain A/P R/8/34 (H 1N 1) obtained from the Japan National Institute of Health (Tokyo, Japan) was passed twice in the allantoic cavity of 10-day-old embryonated chicken eggs (48 h incubation) and allantoic fluid was stored at -70 °C. The New Jersey strain of vesicular stomatitis virus (VSV) was grown in L cell culture for 48 h and the culture supernatant was used as virus stock.
Cell lines. Madin-Darby canine kidney (MDCK) and L cell lines were maintained in culture in Eagle's MEM (Nissui Pharmaceutical Co., Tokyo, Japan) supplemented with 10~ calf serum (CS; Gibco).
Virus titration by MDCK cell plaque assay and by lethal dose for 50 % of embryonated eggs (ELDso). A plaque assay was carried out by a minor modification of the method of Lukacher et al. (1984) . The liver and lungs obtained from mice anaesthetized lightly with ether after bleeding from the axillary artery and vein were homogenized in 10 ml of phosphate-buffered saline (PBS) at 4 °C with a Teflon homogenizer. Two ml of each homogenate was disrupted by sonication (200 W, 2 A, for 10 min, Insonator model 200 M, Kubota K.K., Japan) and centrifuged (10000g for 2 rain) to remove debris. Supernatants were stored at -70 °C until titration. Tenfold dilutions of the supernatant and blood cell suspension were prepared in PBS supplemented with 0.25 ~ bovine serum albumin (BSA; Fraction V powder, Sigma). MDCK cell monolayers prepared by seeding 4 × 105 ceils in 2 ml MEM supplemented with 10~o foetal CS (FCS; Gibco) into tissue culture dishes (35 × 10, Nunc) or into individual wells of multiwell tissue culture plates (Falcon 3046) 2 days previously were inoculated with 0.1 ml of the diluted specimens for 60 min at room temperature. After adsorption, the virus inoculum was removed and each monolayer was washed twice with 1.5 ml of Hanks' solution (Nissui) to remove trypsin inhibitors in the organ homogenate and blood cell suspension, and then overlaid with 2 ml of agar medium consisting of MEM with 0.45 ~ BSA, 0.2~ vitamins ( × 100, Difco), 2 mM-glutamine, 100 ~tg/ml glucose, 2 ~tg/ml folic acid, 2 ~tg/ml biotin, 100 p.g/ml DEAE-dextran, 100 ~tg/ml streptomycin, 100 units/ml penicillin, 0-8 ~o purified agar (Difco) and 2.5 ~tg/ml trypsin (2 x crystallized, Sigma). After 2 days of incubation in 5~ CO2 atmosphere at 37 °C, 1 ml of a second agar medium containing 0.003~ neutral red, but lacking glucose, DEAE-dextran and trypsin, was added to each dish or well. The cultures were incubated for 18 h and plaques were then counted. Each titration point of individual samples was assayed in triplicate. Results were expressed as the mean p.f.u. + s.B./organ from eight mice.
A fertile egg technique was also employed for detection of virus in whole blood. Heparinized blood was collected from eight mice of each group, stored at -70 °C and sonicated (200 W, 2 A for 5 rain) before titration. Five to six eggs were inoculated intra-amniotically with 0.1 ml of each tenfold dilution of the heparinized blood sample. Viability of inoculated eggs was assessed under a light after 4 days and the ELDso was determined according to Reed & Muench (1938) . The result was expressed as the mean ELDs0 + S.D. of three experiments.
Serological testing. Neutralizing antibodies and non-specific inhibitors were titrated by plaque assay in MDCK cells. Test sera obtained from eight mice were treated with receptor-destroying enzyme (Takeda Pharmaceutical, Osaka, Japan) at 37 °C for 18 h and incubated at 56 °C for 30 min. About 1000 to 2000 p.f.u./ml of the virus suspension was mixed with an equal volume of a twofold dilution of test serum, incubated at 37 °C for 1 h and the virus titre in the mixture was determined by MDCK cell plaque assay. Results were expressed as the NDs0 value, i.e. the reciprocal of the dilution causing 50~ reduction of plaque number, calculated from each titration point. Neumann & Sorg (1977) . Briefly, L cells (2000 cells/10 ~1) were placed into each well of a microplate (Falcon 3034), incubated at 37 °C for 6 h in a 5~ CO2 atmosphere and the medium was discarded. Fifteen ~tl of twofold dilutions of each serum, prepared with MEM supplemented with 5~ FCS, were added to the wells and the plate was further incubated at 37 °C for 20 h. After washing twice with MEM, 50 TCIDs0 of VSV in 10 ~1 of MEM was added to the wells and the plate was incubated for 2 days. All tests were performed in triplicate. Cell and virus controls were included on each plate. The IFN titre was determined in International Units (IU) by reference to standard mouse interferon-c~/~ (Enzo Biochemicals, New York, N.Y., U.S.A.).
Assay for interferon (IFN). Serum IFN was assessed according to
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× 107 cells/0.2 ml) were injected intravenously into y-irradiated BALB/c mice after virus inoculation. The purity of the PMN suspension was more than 97~, as assessed histologically after Giemsa staining.
Gamma-ray irradiation and carrageenan treatment. These treatments were carried out as described by Tsuru et al. (1983) . Mice were exposed to 1000 rad whole body irradiation, using a 6°Co machine. Carrageenan type II (Sigma) dissolved in distilled water was injected intraperitoneally into mice at 200 mg/kg. Both treatments were carried out 2 days before virus infection.
RESULTS

Virus titres in the liver and lung
One h after intravenous inoculation with 1 x 108 p.f.u, of a non-lethal dose of virus into untreated and carrageenan-treated mice, approximately 0.1 ~ of the inoculum was detected in the liver as infectious virus. The virus titre decreased gradually by day 3, and was undetectable from day 5 (Fig. 1 a) . In the lung, the time course of the decrease was similar to that in the liver, except that the titre was initially tenfold higher (Fig. lb) . No mouse in either group had died by day 9. With 7-irradiated mice, the degrees of trapping of virus by 1 h in both the liver and lung were similar to those in untreated and carrageenan-treated mice. However, on day 1, the virus titres in y-irradiated mice showed only a slight decrease, in contrast to the marked reductions in untreated and carrageenan-treated mice. From days 3 to 7, the titre increased progressively (Fig.  1 ) and all these mice died within 8 days.
Virus titres in the blood
Virus titres in the blood after virus inoculation declined by day 3 in all three groups. Titres in untreated and carrageenan-treated mice gradually decreased thereafter, whereas the virus titre in y-irradiated mice was higher than in untreated and carrageenan-treated mice from 1 h after virus inoculation and markedly increased from day 5 (Fig. 2) .
Elimination of virus from the blood in the very early phase after the inoculation
This was assessed 18 h after inoculation. The titre in y-irradiated mice was higher than in the other two groups in the very early phase after inoculation (Fig. 3) , indicating that the clearance of virus from the blood was retarded by y-irradiation (Fig. 3) . * Mice were exposed to 1000 rad of whole body v-rays 2 days before intravenous inoculation with influenza virus (1.0 x 108 p.f.u.).
? Mice were intravenously injected with 3 x 10 v and 5 x 107 cells of PMN 1 and 2 days, respectively, after virus inoculation.
{: Results are expressed as the mean value + S.D. for eight mice.
Production of antibody to influenza virus
The antibody titre in untreated mice increased from day 4 (1:64) and a very low titre (1:16) was detected in the carrageenan-treated mice on day 3 after the inoculation. The titres in both groups reached a similar maximum (1 : 320) on days 5 and 7. No increase in the antibody titre was seen in v-irradiated mice by day 7 (Fig. 4) .
IFN levels in the serum
Although IFN at 500 IU was detected in the blood of untreated mice on day 1 after the inoculation, serum IFN was not detectable in either carrageenan-treated or v-irradiated mice up to day 7 (data not shown).
Adoptive transfer of syngeneic PMN into v-irradiated mice
Syngeneic PMN were adoptively transferred into y-irradiated mice 1 and 2 days after virus inoculation. Virus titres in the liver and lung on day 3 were determined. The titres in v-irradiated mice increased approximately fivefold compared with those of untreated mice, whereas increases in the virus titres were almost completely prevented by adoptive transfer into Virradiated mice (Table 1) .
Effects of y-irradiation and carrageenan treatment on non-specific inhibitors
Non-specific inhibitors in serum were measured 3 days after these treatments. There was no difference in the activities of the inhibitors among untreated or treated mice (data not shown).
DISCUSSION
From the results of this study, it is evident that PMN are the cells responsible for protection in the early phase of infection resulting from intravenous inoculation with influenza virus. After inoculation, the initial decrease of the virus titre on day 1 in the liver and lung were reduced by)'-irradiation but not by carrageenan treatment (Fig. 1) . A progressive increase of the influenza virus titre from day 3 after inoculation was observed in the liver and lung of )'-irradiated mice whereas carrageenan treatment did not lead to such an augmentation of the titre (Fig. 1) . Blood virus titres were reduced by day 3 in all three groups but increased rapidly after day 5 only in )'-irradiated mice (Fig. 2) , suggesting that high titres of virus in the liver and lung of )'-irradiated mice by day 3 after inoculation were not due to trapping of a large amount of virus from the blood. Adoptive transfer with PMN prevented the increases in the virus titre in the liver and lung of )'-irradiated mice (Table 1) . On the other hand, serum IFN was detected on day 1 only in untreated mice and non-specific inhibitors were not influenced by either ),-irradiation or carrageenan treatment (data not shown). These observations imply that PMN cells, which are )'-sensitive and carrageenan-resistant (Taliaferro & Taliaferro, 1951; Kornfeld & Greenman, 1966; Nelson, 1969; Tatsukawa et al., 1979) , play a protective role in the elimination of influenza virus in the early phase, at least by day 3, of the infection. This interpretation was supported by the histological observation that most pulmonary inflammatory cells at 3 days after the intravenous inoculation were PMN and not of mononuclear cells (data not shown). Mims (1960) noted that influenza virus was taken up and destroyed by liver macrophages when the virus was injected intravenously, and suggested that liver macrophages played a protective role in the initial phase of the infection. In the present study, however, the clearance of blood virus in the very early stage of the infection was not retarded by treatment with carrageenan (Fig. 3) . This discrepancy might be attributed to differences in the viruses, doses of inoculated virus, or mouse strains.
It has been reported that the antibody response to influenza virus correlates well with the protection against and recovery from the virus infection (Virelizer, 1975; Schulman, 1975) . In the present study, a low antibody titre (1:16) was observed on day 3 in carrageenan-treated but not in other groups of mice (Fig. 4) . In addition, injection of anti-influenza virus serum into mice inoculated intravenously with the virus 2 days after v-irradiation to give an antibody titre of 1 : 16 on day 3 did not reduce virus titres in organs, in comparison with those in the controls (data not shown). These results indicate that the contribution of antibody alone to the early protection against the primary influenza virus infection might be less important than that of PMN.
Recent studies have suggested that NK cells might play a significant role in non-specific resistance in several virus infections in vitro (Santoli et al., 1978 ; Welsh & Hallenbeck, 1980) and in vivo (Bukowski et al., 1983; Habu et al., 1984) . On the other hand, investigations on the influence of X-irradiation on NK cell activity have demonstrated that the activity was resistant to high doses (Kiessling et al., 1977; Hochman et al., 1978) . Cudkowicz & Hochman (1979) reported that NK cells were sensitive to treatment with carrageenan in vitro and in v&o. If NK cells were the main contributors to protection against influenza virus in the early phase of the infection, virus replication during the period would be enhanced by treatment with carrageenan but not by v-irradiation, in contrast with our results. Thus, it seems unlikely that the elimination of influenza virus in the initial phase of the infection depends mainly upon NK cells.
Using the intranasal infection model, further studies are underway to elucidate the significance of PMN in the early phase of influenza virus infection, since the virus infection naturally occurs through the upper respiratory tract (Fujisawa et al., 1987) .
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